Annual Current Liabilities
$53.21 M
+$47.47 M+826.11%
December 1, 2023
Summary
- As of February 7, 2025, ORMP annual total current liabilities is $53.21 million, with the most recent change of +$47.47 million (+826.11%) on December 1, 2023.
- ORMP annual current liabilities is now at all-time high.
Performance
ORMP Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$5.27 M
+$1.54 M+41.25%
September 1, 2024
Summary
- As of February 7, 2025, ORMP quarterly total current liabilities is $5.27 million, with the most recent change of +$1.54 million (+41.25%) on September 1, 2024.
- Over the past year, ORMP quarterly current liabilities has dropped by -$47.94 million (-90.09%).
- ORMP quarterly current liabilities is now -93.25% below its all-time high of $78.17 million, reached on September 30, 2023.
Performance
ORMP Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
ORMP Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +826.1% | -90.1% |
| 3 y3 years | - | -17.8% |
| 5 y5 years | +902.5% | -0.7% |
ORMP Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +826.1% | -93.3% | +394.2% |
| 5 y | 5-year | at high | +1073.2% | -93.3% | +394.2% |
| alltime | all time | at high | >+9999.0% | -93.3% | >+9999.0% |
Oramed Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.27 M(+41.3%) |
| Jun 2024 | - | $3.73 M(-88.9%) |
| Mar 2024 | - | $33.56 M(-36.9%) |
| Dec 2023 | $53.21 M(+826.1%) | $53.21 M(-31.9%) |
| Sep 2023 | - | $78.17 M(+7226.6%) |
| Jun 2023 | - | $1.07 M(-78.5%) |
| Mar 2023 | - | $4.97 M(-13.5%) |
| Dec 2022 | $5.75 M(-22.0%) | $5.75 M(-11.9%) |
| Sep 2022 | - | $6.53 M(+1.7%) |
| Jun 2022 | - | $6.42 M(+1.5%) |
| Mar 2022 | - | $6.32 M(-17.4%) |
| Dec 2021 | $7.37 M(+10.3%) | - |
| Nov 2021 | - | $7.66 M(+14.7%) |
| Aug 2021 | $6.68 M(+47.2%) | $6.68 M(+16.2%) |
| May 2021 | - | $5.75 M(-3.1%) |
| Feb 2021 | - | $5.93 M(+3.3%) |
| Nov 2020 | - | $5.74 M(+26.6%) |
| Aug 2020 | $4.54 M(-14.5%) | $4.54 M(+9.7%) |
| May 2020 | - | $4.13 M(-19.8%) |
| Feb 2020 | - | $5.16 M(+11.1%) |
| Nov 2019 | - | $4.64 M(-12.6%) |
| Aug 2019 | $5.31 M(+16.6%) | $5.31 M(+1.8%) |
| May 2019 | - | $5.22 M(+2.2%) |
| Feb 2019 | - | $5.10 M(+22.6%) |
| Nov 2018 | - | $4.16 M(-8.5%) |
| Aug 2018 | $4.55 M(-11.8%) | $4.55 M(-19.2%) |
| May 2018 | - | $5.64 M(+19.5%) |
| Feb 2018 | - | $4.72 M(-7.9%) |
| Nov 2017 | - | $5.12 M(-0.8%) |
| Aug 2017 | $5.17 M(+42.6%) | $5.17 M(+2.6%) |
| May 2017 | - | $5.04 M(+2.1%) |
| Feb 2017 | - | $4.93 M(+4.2%) |
| Nov 2016 | - | $4.73 M(+30.7%) |
| Aug 2016 | $3.62 M(+143.2%) | $3.62 M(+170.6%) |
| May 2016 | - | $1.34 M(-11.9%) |
| Feb 2016 | - | $1.52 M(+16.5%) |
| Nov 2015 | - | $1.30 M(-12.4%) |
| Aug 2015 | $1.49 M | $1.49 M(+94.6%) |
| May 2015 | - | $765.00 K(+26.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Feb 2015 | - | $605.00 K(-26.8%) |
| Nov 2014 | - | $827.00 K(-15.0%) |
| Aug 2014 | $973.00 K(+95.4%) | $973.00 K(+96.6%) |
| May 2014 | - | $495.00 K(+41.5%) |
| Feb 2014 | - | $349.80 K(-47.7%) |
| Nov 2013 | - | $668.50 K(+34.2%) |
| Aug 2013 | $498.00 K(-22.7%) | $498.00 K(+11.7%) |
| May 2013 | - | $446.00 K(-5.0%) |
| Feb 2013 | - | $469.40 K(+40.3%) |
| Nov 2012 | - | $334.60 K(-48.1%) |
| Aug 2012 | $644.40 K(+46.0%) | $644.40 K(+81.1%) |
| May 2012 | - | $355.90 K(-38.9%) |
| Feb 2012 | - | $582.20 K(+37.2%) |
| Nov 2011 | - | $424.40 K(-3.8%) |
| Aug 2011 | $441.30 K(-3.8%) | $441.30 K(+22.7%) |
| May 2011 | - | $359.80 K(-36.4%) |
| Feb 2011 | - | $565.80 K(+48.0%) |
| Nov 2010 | - | $382.40 K(-16.6%) |
| Aug 2010 | $458.60 K(+24.4%) | $458.60 K(+60.2%) |
| May 2010 | - | $286.30 K(+1.4%) |
| Feb 2010 | - | $282.40 K(-31.4%) |
| Nov 2009 | - | $411.60 K(+11.7%) |
| Aug 2009 | $368.60 K(-59.7%) | $368.60 K(-22.4%) |
| May 2009 | - | $475.00 K(-12.7%) |
| Feb 2009 | - | $543.80 K(-17.6%) |
| Nov 2008 | - | $660.20 K(-27.8%) |
| Aug 2008 | $914.00 K(-35.8%) | $914.00 K(-61.3%) |
| May 2008 | - | $2.36 M(+151.7%) |
| Feb 2008 | - | $939.00 K(+4.9%) |
| Nov 2007 | - | $895.00 K(-37.1%) |
| Aug 2007 | $1.42 M(+133.9%) | $1.42 M(-18.1%) |
| May 2007 | - | $1.74 M(+142.9%) |
| Feb 2007 | - | $715.90 K(+26.1%) |
| Nov 2006 | - | $567.70 K(-6.8%) |
| Aug 2006 | $608.90 K(+1220.8%) | $608.90 K(+64.7%) |
| May 2006 | - | $369.70 K(+619.3%) |
| Feb 2006 | - | $51.40 K(+3.2%) |
| Nov 2005 | - | $49.80 K |
| Aug 2005 | $46.10 K | - |
FAQ
- What is Oramed Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Oramed Pharmaceuticals?
- What is Oramed Pharmaceuticals annual current liabilities year-on-year change?
- What is Oramed Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Oramed Pharmaceuticals?
- What is Oramed Pharmaceuticals quarterly current liabilities year-on-year change?
What is Oramed Pharmaceuticals annual total current liabilities?
The current annual current liabilities of ORMP is $53.21 M
What is the all time high annual current liabilities for Oramed Pharmaceuticals?
Oramed Pharmaceuticals all-time high annual total current liabilities is $53.21 M
What is Oramed Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, ORMP annual total current liabilities has changed by +$47.47 M (+826.11%)
What is Oramed Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of ORMP is $5.27 M
What is the all time high quarterly current liabilities for Oramed Pharmaceuticals?
Oramed Pharmaceuticals all-time high quarterly total current liabilities is $78.17 M
What is Oramed Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, ORMP quarterly total current liabilities has changed by -$47.94 M (-90.09%)